FDA advisors vote to lift restrictions on six wellness peptides — over staff scientists' objections

August 5, 2026  |  10:00 AM – 1:00 PM ET

An FDA advisory committee voted last week to lift restrictions on six popular wellness peptides. FDA staff scientists objected, saying the safety and efficacy data aren't there.

GLP-1s were just the beginning. Consumers are already seeking out peptides through above-board, gray and illicit markets, from the US and abroad. The question now is whether an FDA policy shift reshapes the supply.

On August 5, we'll dig in. The peptide market is at an inflection point. Join us to hear what comes next.

SPONSORED BY